Clinical Trials Browser

Phase 3 × Small Cell Lung Cancer Limited Stage × Clear all

NCT06469879 2024-07-01

A Clinical Study of TQB2450 Combined With Anlotinib in Limited-Stage Small Cell Lung Cancer Patients

Phase 3 Not yet recruiting

Small Cell Lung Cancer Limited Stage